Overview
Indian childhood cirrhosis (ICC) is a severe form of liver disease predominantly affecting young children in India, characterized by progressive liver fibrosis and cirrhosis. 1Diagnosis
Genetic testing for C3F gene is recommended due to its significant association with ICC (relative risk 12.5). 1
Serological testing for hepatitis A virus (HAV) antibodies is not routinely indicated as prevalence in patients with ICC is similar to controls. 2Management
No specific first-line treatments are highlighted in the provided abstracts.
Further research is needed to establish definitive management strategies beyond supportive care.Special Populations
No specific considerations for pregnancy, pediatrics, elderly, or comorbidities are detailed in the abstracts provided.Key Recommendations
Genetic screening for the C3F gene should be considered in pediatric populations at high risk for ICC to aid in early identification. (Evidence: Moderate) 1
Routine serological testing for hepatitis A virus antibodies is not recommended for diagnosing ICC due to non-distinctive prevalence rates compared to controls. (Evidence: Moderate) 2
Establish definitive management protocols through further clinical trials and observational studies given the current lack of specific treatment guidelines. (Evidence: Expert opinion)References
1 Srivastava N, Srivastava LM. Association between C3 complement types and Indian childhood cirrhosis. Human heredity 1985. link
2 Agarwal SS, Lahori UC, Mehta SK, Bajpai PC, Werner B, Bradley DW. Hepatitis A and Indian childhood cirrhosis. Archives of disease in childhood 1979. link